BSECompany Update4d ago · 7 Aug 2026, 12:36 pm
Newspaper publication- un-audited finacial results
Suven Life Sciences Ltd · 530239
✦ AI SummaryResults
Suven Life Sciences Ltd has published its un-audited financial results for the quarter ended June 30, 2026, showing a net loss of Rs. 1611.91 lakhs for the period.
Analysis Scores
Earnings Impact1/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment3/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Suven Life Sciences Ltd - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Attachments (1)
📄pdf
Download →
64f3d29f-ee1c-48d8-9c81-f64da9a094d5.pdf
View document text
SUVEN®
Life Sciences
CSD/BM/SE/2026-27
Date: August 7, 2026
To To
Department of Corporate Services Listing Department
BSE Limited National Stock Exchange of India Limited
25th Floor, P. J. Towers, Exchange Plaza, Bandra Kurla Complex
Dalal Street, Mumbai - 400 001 Bandra (E), Mumbai – 400 051
Scrip Code: 530239 Scrip Symbol: SUVEN
Dear Sir/Madam,
Sub: Newspaper advertisement – Un-audited Financial Results
Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, please find enclosed copies of
newspaper advertisements regarding un-audited financial results of the Company for the
quarter ended June 30, 2026. The advertisements appeared in Andhra Prabha (Telugu) and
Business Standard (English) on 7th August, 2026.
The above information is also available at : https://www.suven.com/newspaperads.aspx
This is for your information and records.
Thanking you.
Yours faithfully,
For Suven Life Sciences Limited
K. Sangeetha Laxmi
Company Secretary and Compliance officer
Encl: as above
Suven Life Sciences Limited
Registered Office: 8-2-334 I SDE Serene Chambers I 6th Floor Road No.5 I Avenue 7
Banjara Hills I Hyderabad – 500 034 I Telangana I India I CIN: L24110TG1989PLC009713
Tel: 91 40 2354 1142/ 1152 Email: info@suven.com website: www.suven.com
,ib~7-8-2026
a... a...
~~Oc! s-c-g1:,@o: 8-2-334, .:l~~:R ~~5 ij)"oa.i5;i, 6~ ~oc!~. 11~ o.5, e,;,~£ 7, a.io.::-0"".l'J.), 500 034, 01:,011'~, :RO~@.
~.o.)5: .)e5"24110~l!l1989~.)~009713 &'l!l: 91 40 2354 1142 / 1152
zi-';3.o;i;ie5°: investorservices@suven.com, ~~!:!~' www.suven.com
30 ~~. 2026ga ~a,(6 !cfuaa,~ §°at5~ ~ i.5'a1>&>
~ 30/06/2026 31/03/2026 30/06/2025 30/06/2026 31/03/2026 30/06/2025
iOO.
1 ~tooa~ecad1>o 356.58 711.47 186.67 356.58 711.47 186.67
2 ~tll<IO~~~ (1611.91) (5486.28) (1477.87) (12761.03) (27634.41) (5151.69)
3 lll!O<llCl<>~~m=c (1611.91) (5486.28) (1477.87) (12761.03) (27634.41) (5151.69)
4 &ll!l:)""10so.,ag,A_~~ c ,m (1611.91) (5486.28) (1477.87) (12761.03) (27634.41) (5151.69)
lL\lfJa1}.)/.S:,. ~WO<l~)
5 ~~~eaod (1617.46) (5508.47) (1479.37) (12764.63) (27752.80) (5156.81)
6 ~ illb ~ 2639.93 2637.20 2180.74 2637.20 2639.93 2180.74
7 ~~(6~~~ 147699.51 56502.76
8 ~iil>P~ C0,..1/-..:,,-'~)
1.&I: " (0.61) (2.41) (0.68) (4.84) (12.13) (2.36)
2.~: (0.61) (2.41) (0.68) (4.84) (12.13) (2.36)
&, : ~ 06, 2026 ~:00278028
Busines Stand rd
HYDERABAD I FRIDAY, 1 AuGusr 2026
SUVEN LIFE SCIENCES LIMITED
Regd Office: 8-2-334, SD£ Serene Chambers, 6th Floor Road No. 5, Avenue 7, BanJara Hills, 500 034, Telangana, India.
CIN: 1.241 l0TGl 989PLC009713 Tel: 9140 2354 1142 / 1152
Email: mvestorservices(asuven com Website: www.suven com
EXTRACT OF UN-AUDITED STANDALONE & CONSOLIDATED FINANCIAL RESULTS
FOR THE QUARTER ENDED 30 JUNE, 2026
(? in Lakh,1
STANDAWNE CONSOLIDATED
SI. Qtr Ended Year Ended Qtr Ended Qtr Ended Year Ended Qtr Ended I
Particulars
No. 30/06/2026 31/03/2026 30/06/2025 30/06/2026 31/03/2026 30/06/2025
Un-Audited Audited Un-Audited Un-Audited Audited Un-Audited
1 Total income from operations 356.58 711.47 186.67 356.58 711.47 186.67 I
2 Net profit for the period (before tax, (1611.91) (548628) (147787) (12761.03) (2763441) (5151.69)
exceptional and/or extraordinary items)
3 Net profit for the period before tax (after (1611.91) (5486.28) (1477.87) (12761.03) (27634.41) (515169)
exceptional and/or extraordinary items)
4 Net profit for the period After tax (after (1611.91) (5486.28) (1477.87) (12761.03) (27634.41) (5151.69)
exceptional and/or extraordinary items)
5 Total comprehensive income for the (1617 46) (5508.47) (1479.37) (1276463) (27752.80) (515681)
perioa [comprising profit for the period
(after tax) and other comprehensive
income (after tax)
6 Equity share capital 2639.93 2637.20 2180.74 2637.20 2639.93 2180.74
7 Other Equity (Excluding Revaluation 147699.51 56502.76
Reserve) as shown in the audited balance
sheet
8 Earnings Per Share (of Rs. 1.00/-each)
1. Basic (0.61) (2.41) (068) (4.84) (12.13) (2.36)
2. Diluted (061) (2.41) (0.68) (4.84) (12.13) (2.36)
(not annualised) (annualised) (not annualised) (not annualised) (annualised) (not annualised)
Note: The above is an extract of the detailed format of Quarterly / Annual Rnancial Results filed with the Stock Exchanges under Regulation 33 of the SEBI
(Llsting and Other Disclosure Requirements) Regulations, 2015. The full format of the Quarterly/ Annual Rnancial Results are available on the websites of the
stock exchanges(s) and the listed entity. (www.bseindia.com and www.nseindia.com) and company's website www.suven.com. You may refer QR code given
below to dowhload full results.
For SUVEN LIFE SCIENCES LID
■: Sd/
'Iii
VENKAT JASTI
Place : Hyderabad I,, Chairman & MD
Date : August 06, 2026 I!] •. DIN: 00278028